Email this article Clinical and epidemiological features of psoriasis in the Republic of Uzbekistan
- Authors: Olisova O.Y.1, Melikova N.I.1, Tashkenbaeva U.A.2, Torchinskiy N.V.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Tashkent Medical Academy
- Issue: Vol 25, No 2 (2022)
- Pages: 127-132
- Section: DERMATOLOGY
- URL: https://journal-vniispk.ru/1560-9588/article/view/108631
- DOI: https://doi.org/10.17816/dv108631
- ID: 108631
Cite item
Open Access
Access granted
Subscription Access
Abstract
BACKGROUND: Psoriasis is one of the most common dermatoses. The disease has a negative impact on every aspect of the patient’s life ― social, physical and psychological. Psoriasis is accompanied by a marked deterioration in the quality of life of patients, which often leads to their social maladaptation.
AIMS: This study is aimed at assessing the nature of epidemiological and clinical manifestations of psoriasis in the Republic of Uzbekistan.
MATERIALS AND METHODS: The data of the population register of psoriatic diseases created on the basis of the Republican Skin and Venereological Clinical Hospital the city of Tashkent, the Republican Specialized Scientific and Practical Center of Dermatology and Cosmetology of the Republic of Uzbekistan were studied. A retrospective analysis of case histories for the period 2015–2019 was also carried out at the clinical base of the Department of Dermatovenerology of the Tashkent Medical Academy.
RESULTS: The prevalence of psoriasis among the general population of the Republic of Uzbekistan from 2010 to 2020 during the study period significantly increased, especially in the age group of 15–29 years. Men suffer from psoriasis more often, this disease is characterized by an earlier onset of the disease (age group up to 40 years). The most common clinical form of psoriasis is vulgar psoriasis.
CONCLUSIONS: There is a clear need to improve the quality and increase the amount of data related to the epidemiology of psoriasis in the Republic of Uzbekistan. Diagnostic criteria and reports on morbidity and prevalence should be standardized.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Olga Yu. Olisova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN-code: 2500-7989
MD, Dr. Sci. (Med.), Professor
Russian Federation, MoscowNigina I. Melikova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: niginamelikova29@gmail.com
ORCID iD: 0000-0003-0404-779X
Graduate Student
Russian Federation, MoscowUmida A. Tashkenbaeva
Tashkent Medical Academy
Email: umidatashkenbaeva@mail.ru
ORCID iD: 0000-0002-4380-6982
SPIN-code: 7902-5210
MD, Dr. Sci. (Med.), Associate Professor
Uzbekistan, TashkentNikolay V. Torchinskiy
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: torchinsky75@mail.ru
ORCID iD: 0000-0003-3835-0842
SPIN-code: 7797-0908
MD, Cand. Sci. (Med.), Associate Professor
Russian Federation, MoscowReferences
- Kuchekar AB, Pujari RR, Kuchekar SB, et al. Psoriasis: a comprehensive review. Int J Pharm Life Sci. 2011;2(6):857–877.
- Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2021;168(6):1303–1310. doi: 10.1111/bjd.12230
- Iskandar IY, Parisi R, Griffiths CE, Ashcroft DM; Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(2):243–258. doi: 10.1111/bjd.19169
- Nordqvist C. All about psoriasis [Internet]. Medical news today. Available from: https://www.medicalnewstoday.com/articles/medical-myths-all-about-psoriasis#Summary. Accessed: 15.01.2022.
- Murphy G, Reich K. In touch with psoriasis: topical treatments and current guidelines. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):3–8. doi: 10.1111/j.1468-3083.2011.04059.x
- Jacobi A, Mayer A, Augustin M. Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review. Dermatol Ther (Heidelb). 2015;5(1):1–18. doi: 10.1007/s13555-015-0068-3
- Pariser D, Schenkel B, Carter C, et al.; Psoriasis Patient Interview Study Group. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. J Dermatol Treat. 2016;27(1):19–26. doi: 10.3109/09546634.2015.1044492
Supplementary files
